The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).

BACKGROUND:Metastatic breast cancer (MBC) remains a devastating and incurable disease. Over the past decade, the implementation of clinical trials both with and without molecular targeted therapeutics has impacted the daily clinical treatment of patients with MBC. In this study, we determine whether...

Full description

Bibliographic Details
Main Authors: Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Su Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4763476?pdf=render